Industry concerned that new products miss special reimbursement
This article was originally published in Clinica
Executive Summary
Medicare's eligibility criteria for its add-on temporary payment for new technology is so stringent that even breakthrough technologies are not qualifying for the special inpatient reimbursement, AdvaMed asserted in comments filed with the Centers for Medicare and Medicaid Services (CMS).